Increase in Shares and Capital Through Exercise of Stock Acquisition Rights
First written in FY2017-Q2. 21 of 22 entries say "Advanced", first in FY2017. Latest entry: FY2025.
103 other companies' latest entry also says "Advanced".
- FY2025AdvancedAnnual report
「1 October 2024 to 31 March 2025 27,800 120,689,300 24 20,173 24 19,956 (Note) Increase through the exercise of stock acquisition rights.」
During the interim accounting period, the exercise of stock acquisition rights increased the number of shares by 27,800 and increased capital stock and capital surplus by ¥24 million each. For the full year, the increase was 48,200 shares. - FY2025-H1AdvancedAnnual report
「1 October 2024 to 31 March 2025 27,800 120,689,300 24 20,173 24 19,956 (Note) Increase through the exercise of stock acquisition rights.」
During the interim accounting period, the exercise of stock acquisition rights increased the number of issued shares by 27,800 and increased capital stock and capital surplus by ¥24 million each. - FY2024-Q2AdvancedAnnual report
「(Note) Increase due to exercise of stock acquisition rights.」
Between January and March 2024, the number of issued shares increased by 48,300 through the exercise of stock acquisition rights, while capital stock and capital surplus each increased by ¥21 million. - FY2023AdvancedAnnual report
「The increase in issued common shares resulted from the exercise of stock options for 100,200 shares.」
During the consolidated fiscal year, the exercise of stock acquisition rights increased the number of shares by 100,200, while capital stock and capital surplus each increased by ¥40 million. - FY2023-Q2AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
Between January and March 2023, the number of issued shares increased by 80,000 through the exercise of stock acquisition rights, while capital stock and capital surplus each increased by ¥31 million. - FY2022-Q2AdvancedAnnual report
「1 January 2022 to 31 March 2022 (Note) 2 149,000 126,284,700 75 20,070 75 19,853 (Note) 2. Increase through the exercise of stock acquisition rights.」
Between January and March 2022, the number of shares increased by 149,000 through the exercise of stock acquisition rights, while capital stock and capital surplus each increased by ¥75 million. - FY2022-Q1AdvancedAnnual report
「Pursuant to a resolution of the Board of Directors dated 20 January 2022, new shares were issued as restricted stock compensation on 10 February 2022. As a result, the number of shares increased by 18,700 and the total number of issued shares became 126,135,700.」
The company issued 18,700 new shares as restricted stock compensation, bringing the total number of issued shares to 126,135,700. - FY2021AdvancedAnnual report
「The increase of 297,900 issued common shares resulted from an increase of 275,200 shares through the exercise of stock options and 22,700 shares through the grant of restricted stock.」
The number of issued shares increased by 297,900 in total through the exercise of stock acquisition rights and the grant of restricted stock. - FY2021-Q3AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
Between April and June 2021, the number of issued shares increased by 152,000 through the exercise of stock acquisition rights, while capital stock and capital surplus each increased by ¥101 million. - FY2021-Q2AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
Between January and March 2021, the number of issued shares increased by 83,600 through the exercise of stock acquisition rights, while capital stock and capital surplus each increased by ¥32 million. - FY2021-Q1AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
Between October and December 2020, the number of issued shares increased by 21,600 through the exercise of stock acquisition rights, while capital stock and capital surplus each increased by ¥8 million. - FY2020AdvancedAnnual report
「The increase of 68,200,600 issued common shares resulted from an increase of 57,618,500 shares through a stock split, 9,617,200 shares through a public offering, 684,600 shares through a private placement, 254,800 shares through the exercise of stock options, and 25,500 shares through the grant of restricted stock.」
The number of shares increased by 254,800 through the exercise of stock options and by 25,500 through restricted stock compensation. - FY2020-Q2AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
Between 6 February and 31 March 2020, the number of issued shares increased by 72,800 through the exercise of stock acquisition rights, while capital stock and capital surplus each increased by ¥32 million. - FY2020-Q1AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
Between October and December 2019, the number of issued shares increased by 21,200 through the exercise of stock acquisition rights, while capital stock and capital surplus each increased by ¥8 million. - FY2019AdvancedAnnual report
「The increase of 106,000 issued common shares resulted from an increase of 88,800 shares through the exercise of stock options and 17,200 shares through the grant of restricted stock compensation.」
The number of issued shares increased by 106,000 in total through the exercise of stock options and restricted stock compensation. - FY2019-Q3AdvancedAnnual report
「The increase resulted from the issuance of new shares as restricted stock compensation.」
Between April and June 2019, 8,100 new shares were issued as restricted stock compensation, increasing capital stock and capital surplus by ¥16 million each. - FY2019-Q2AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights and the issuance of new shares as restricted stock compensation.」
Between 1 January and 31 March 2019, the exercise of stock acquisition rights and the issuance of new shares as restricted stock compensation increased the total number of issued shares by 42,300 and increased capital stock and capital surplus by ¥46 million each. - FY2019-Q1AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights and the issuance of new shares as restricted stock compensation.」
During the cumulative period of the quarter, the exercise of stock acquisition rights and the issuance of new shares as restricted stock compensation increased the total number of issued shares by 40,000 and increased capital stock and capital surplus by ¥63 million each. - FY2018AdvancedAnnual report
「The increase of 48,900 issued common shares resulted from an increase of 39,600 shares through the exercise of stock options and 9,300 shares through the grant of restricted stock compensation.」
The number of issued shares increased by 48,900 in total through the exercise of stock options and restricted stock compensation. - FY2018-Q2AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights and the issuance of new shares as restricted stock compensation.」
Between 1 January and 31 March 2018, the total number of issued shares increased by 38,700 for these reasons, while capital stock and capital surplus each increased by ¥52 million. - FY2017AdvancedAnnual report
「The number of issued shares increased by 63,600 through the exercise of stock options.」
The issuance of 63,600 shares through the exercise of stock acquisition rights increased capital stock and capital surplus by ¥50 million each. - FY2017-Q2First statedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
Between 1 January and 31 March 2017, the number of shares increased by 26,200 through the exercise of stock acquisition rights, while capital stock and capital surplus each increased by ¥20 million.